FDA to take an­oth­er look at Ake­bi­a's re­ject­ed kid­ney drug

3 years ago
Pharma
FDA+

Big Phar­ma has harsh words for UK's bal­loon­ing vol­un­tary re­im­burse­ment agree­ment

3 years ago
Pharma

BIO re­news video se­ries with new phar­ma part­ners, in­clud­ing Pfiz­er, Eli Lil­ly and Mer­ck

3 years ago
Pharma
Marketing

Myeloid Ther­a­peu­tics goes down un­der for new man­u­fac­tur­ing site, with $66M lo­cal in­vest­ment

3 years ago
Pharma
Cell/Gene Tx

Mar­ket­ingRx roundup: CVS amps Mod­er­na’s CMV vac­cine tri­al; An­oth­er star in Pfiz­er’s Covid vac­ci­na­tion sky

3 years ago
Pharma
Marketing

The new phar­ma celebri­ties: Fa­mous pa­tients with so­cial in­flu­ence are ‘just get­ting start­ed’

3 years ago
Pharma
Marketing

Mer­ck falls short in PhI­II Covid-19 pro­phy­lax­is tri­al, join­ing Pfiz­er

3 years ago
R&D
Coronavirus

Can­cer biotech ends tri­al, search­es for sale or oth­er route

3 years ago
People
R&D

Bridge Bio­ther­a­peu­tic­s' ul­cer­a­tive col­i­tis drug fails Phase II tri­al; biotech plans to push for­ward

3 years ago
R&D

Al­ny­lam gets an ad­comm for On­pat­tro treat­ment in AT­TR amy­loi­do­sis

3 years ago
FDA+

Up­dat­ed: Leena Gand­hi leaves Dana-Far­ber for check­point in­hibitor biotech

3 years ago
People

A small Con­necti­cut biotech throws hat in­to IPO ring

3 years ago
Financing
Startups

En route to BLA fil­ing, Ac­tini­um de­tails PhI­II win for tar­get­ed ra­dio­ther­a­py in acute myeloid leukemia

3 years ago
R&D

Astel­las' menopause drug hit by FDA de­lay af­ter spend­ing $97M on a pri­or­i­ty re­view vouch­er

3 years ago
R&D
FDA+

Up­dat­ed: Re­silience to cut most staff, sus­pend op­er­a­tions at Mass­a­chu­setts man­u­fac­tur­ing plant

3 years ago
People
Manufacturing

Rare blood dis­or­ders biotech Hemab rais­es $135M, be­gins trek in­to clin­ic

3 years ago
Financing

Lat­est news on two FDA ap­provals; High-pro­file moves for John Reed, Brent Saun­ders, Christi Shaw..; and more

3 years ago
Weekly

FDA clears Tra­vere’s rare kid­ney dis­ease drug, will come with REMS pro­gram

3 years ago
Pharma
FDA+

FDA ap­proves Apel­lis' reti­nal dis­ease drug as com­peti­tor ex­pects Au­gust de­ci­sion

3 years ago
Pharma
FDA+

Dai­ichi Sankyo gets US patent of­fice to restart re­view of Seagen patent

3 years ago
Pharma
Law

Ox­ford Prop­er­ties Group pur­chas­es Re­silience man­u­fac­tur­ing site for $125M

3 years ago
Deals
Pharma

French court over­turns €444M an­titrust fine against Roche, No­var­tis

3 years ago
Pharma
Law

FDA and HHS should im­prove in­sti­tu­tion­al re­view board in­spec­tion prac­tices, GAO says

3 years ago
R&D

FDA's No. 2 on­col­o­gy of­fi­cial de­parts for biotech start­up

3 years ago
People
FDA+
First page Previous page 373374375376377378379 Next page Last page
A service from the Financial Times